Zobrazeno 1 - 10
of 921
pro vyhledávání: '"Somatostatin receptor 1"'
Autor:
Jiri Soukup, Helena Hornychova, Monika Manethova, Kvetoslava Michalova, Ludmila Michnova, Lenka Popovska, Veronika Skarkova, Tomas Cesak, David Netuka, Ales Ryska, Jan Cap, Václav Hána, Michal Kršek, Eva Dvořáková, Michal Krčma, Ivica Lazurova, Věra Olšovská, Karel Starý, Peter Vaňuga, Filip Gabalec
Publikováno v:
Journal of Cellular and Molecular Medicine
In somatotroph pituitary tumours, somatostatin analogue (SSA) therapy outcomes vary throughout the studies. We performed an analysis of cohort of patients with acromegaly from the Czech registry to identify new prognostic and predictive factors. Clin
Publikováno v:
ACS Omega
ACS Omega, Vol 5, Iss 33, Pp 21145-21161 (2020)
ACS Omega, Vol 5, Iss 33, Pp 21145-21161 (2020)
Somatostatin receptor 1 (SSTR1), a subtype of somatostatin receptors, is involved in various signaling mechanisms in different parts of the human body. Like most of the G-protein-coupled receptors (GPCRs), the available information on the structural
Publikováno v:
Brain Structure & Function
Inhibitory interneurons in the cerebral cortex contain specific proteins or peptides characteristic for a certain interneuron subtype. In mice, three biochemical markers constitute non-overlapping interneuron populations, which account for 80–90% o
Autor:
Sofie Eline Tollefsen, Borgny Ytterhus, Øyvind Salvesen, Anders Hagen Jarmund, Sverre H. Torp, Patricia Mjønes
Publikováno v:
Cancers; Volume 13; Issue 22; Pages: 5704
Cancers, Vol 13, Iss 5704, p 5704 (2021)
Cancers
Cancers, Vol 13, Iss 5704, p 5704 (2021)
Cancers
Simple Summary Meningioma diagnostics and grading are currently based on subjective histopathological criteria given by the 2016 World Health Organization (WHO) classification. However, biomarkers may provide a more objective approach to diagnostics.
Autor:
Eeva Ryhänen, Johanna Louhimo, Caj Haglund, Johanna Arola, Helena Leijon, Sara Storvall, Camilla Schalin-Jäntti
Publikováno v:
Endocrine Connections, Vol 8, Iss 8, Pp 1213-1223 (2019)
Endocrine Connections
Endocrine Connections
Introduction Parathyroid carcinoma represents a rare cause of primary hyperparathyroidism. Distinguishing carcinoma from the benign tumors underlying primary hyperparathyroidism remains challenging. The diagnostic criteria for parathyroid carcinoma a
Publikováno v:
International Journal of Gynecological Pathology. 38:371-376
Three types of endometriosis are described: superficial peritoneal endometriosis (SPE), ovarian endometrioma (OMA), and deep infiltrating endometriosis (DIE). The expression of somatostatin receptors (SSTR1, 2, and 5) in human endometrial tissue and
Publikováno v:
General and Comparative Endocrinology. 274:87-96
In the present study, four full-length cDNAs of somatostatin receptor (sstr) were cloned from the forebrain and pituitary of red-spotted grouper. The four full-length cDNAs were designated 2292, 1522, 1873 and 1789 bp and identified as sstr1, sstr2,
Autor:
Martin Syrucek, Veronika Skarkova, Boris Rychly, Petra Kašparová, Jiri Soukup, Filip Gabalec, Ales Kohout
Publikováno v:
Pituitary. 22:70-78
Spindle cell oncocytomas (SCOs) are very rare tumors of the posterior pituitary with potential for locally aggressive behaviour. Their treatment includes surgery and possibly radiotherapy, however other options are lacking. Somatostatin receptors (SS
Autor:
Patrick J. Kenny, Karen M. Richardson, Ruth Gostelow, Yaiza Forcada, David B. Church, Christopher J Scudder, Katarina Hazuchova, Samantha M. Mirczuk, Stijn J. M. Niessen, Márta Korbonits, Imelda M. McGonnell, Norelene Harrington, Robert C. Fowkes, Jacob T. Regan, Victoria J Crossley
Publikováno v:
Journal of the Endocrine Society
The prevalence of GH-secreting pituitary tumors in domestic cats (Felis catus) is 10-fold greater than in humans. The predominant inhibitory receptors of GH-secreting pituitary tumors are somatostatin receptors (SSTRs) and D2 dopamine receptor (DRD2)
Publikováno v:
Pathology, research and practice. 216(9)
Carcinomas of the breast with neuroendocrine features are rare primary neoplasms positive for neuroendocrine markers. According to the WHO classification of tumours of the breast they are divided into three morphologically distinct categories. They c